BIOMAT Database Logo BIOMAT Database Logo

Lowering of hypertension by central saralasin in the absence of plasma renin. 1977

M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012504 Saralasin An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION. 1-Sar-8-Ala Angiotensin II,1-Sarcosine-8-Alanine Angiotensin II,(Sar(1),Ala(8))ANGII,(Sar1,Val5,Ala8)Angiotensin II,Angiotensin II, Sar(1)-Ala(8)-,Angiotensin II, Sarcosyl(1)-Alanine(8)-,Sar-Arg-Val-Tyr-Val-His-Pro-Ala,Saralasin Acetate,Saralasin Acetate, Anhydrous,Saralasin Acetate, Hydrated,1 Sar 8 Ala Angiotensin II,1 Sarcosine 8 Alanine Angiotensin II,Angiotensin II, 1-Sar-8-Ala,Angiotensin II, 1-Sarcosine-8-Alanine,Anhydrous Saralasin Acetate,Hydrated Saralasin Acetate
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Saralasin testing for renin-dependent hypertension.
January 1979, Archives of internal medicine,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
[Diagnostic relevancy of saralasin in renin-dependent hypertension].
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
[Saralasin in subjects with low renin arterial hypertension].
July 1980, Bollettino della Societa italiana di biologia sperimentale,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Renal vein renin and saralasin testing in renovascular hypertension.
November 1978, American heart journal,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Detection of renovascular hypertension: saralasin test versus renin determinations.
October 1976, The Journal of urology,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Vaule of renin measurement, saralasin test, and acebutolol treatment in hypertension.
February 1979, Kidney international,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
June 1977, Mayo Clinic proceedings,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Saralasin bolus test. Rapid screening procedure for renin-mediated hypertension.
October 1975, Lancet (London, England),
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
[Interrelationship between the brain and kidney renin--angiotensin systems in combined hypertension: the effect of a central block with saralasin].
January 1981, Eksperimentalna meditsina i morfologiia,
M I Phillips, and J F Mann, and H Haebara, and W E Hoffman, and R Dietz, and P Schelling, and D Ganten
Systemic and pulmonary hemodynamic effects of saralasin infusion in hypertension. Predictability of plasma renin status from hemodynamic changes.
December 1978, The American journal of cardiology,
Copied contents to your clipboard!